JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholding for the Period Ended September 30, 2021
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Record Date For Interim Dividend: 01 November, 2021.
This is to inform that the Board of Directors has approved and declared an Interim Dividend @ 80% per Equity Shares of face value of Rs. 5/- each, i.e., Rs. 4/- per Equity Share in the Board Meeting held on Tuesday, 19 Day of October, 2021. The Interim Dividend shall be paid to the equity shareholders of the Company, whose names appear on the Register of Members of the Company or in the records of the depositories as beneficial owners of the shares as on Monday, November 01, 2021 which is the Record Date/ Cut-off Date fixed for the purpose of Interim Dividend. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board declares Interim Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 19, 2021, inter alia, has approved an interim dividend @ 80% per Equity Shares of face value of Rs. 5/- each, i.e. Rs. 4/- per Equity Share. Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of the Press Release on the Unaudited Financial results of the Company for the quarter and half year ended 30th September, 2021. Jagsonpal Pharmaceuticals Ltd - 507789 - Standalone Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2021;
Standalone Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2021; Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON OCTOBER 19TH, 2021
Board has approved the Unaudited Financial Results for the quarter and half year ended 30 September, 2021 . Further, the Board has also declared and approved an Interim Dividend @ 80% per Equity Shares of face value of Rs. 5/- each, i.e. Rs. 4/- per Equity Share. The Interim Dividend shall be paid to the equity shareholders of the Company, whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Monday, November 01, 2021 which is the Record Date fixed for the purpose. The book closure will be from 02nd November, 2021 to 3rd November, 2021 for the purpose of Interim Dividend. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74 (5) of SEBl (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended 30th September, 2021. Jagsonpal Pharmaceuticals Ltd - 507789 - Board to consider Interim Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that Meeting of Board of Directors of the Company will be held on October 19, 2021, inter alia, to consider and approve:1. The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021;2. The Limited Review Report on Un-Audited Financial Results of the company for the quarter and half year ended September 30, 2021;3. The declaration of Interim Dividend, if any; JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board to consider Interim Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that Meeting of Board of Directors of the Company will be held on October 19, 2021, inter alia, to consider and approve:1. The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021;2. The Limited Review Report on Un-Audited Financial Results of the company for the quarter and half year ended September 30, 2021;3. The declaration of Interim Dividend, if any; JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Board Meeting Intimation for Quarterly Board Meeting
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2021 ,inter alia, to consider and approve 1. The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2021; 2. The Limited Review Report on Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2021; 3. The declaration of Interim Dividend, if any; 4. Any other agenda items as placed before the Board. Kindly note the same and acknowledge the receipt. 1. The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2021; 2. The Limited Review Report on Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2021; 3. The declaration of Interim Dividend, if any; 4. Any other agenda items as placed before the Board. Kindly note the same and acknowledge the receipt.